MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Derma Sciences Company Profile (NASDAQ:DSCI)

Consensus Ratings for Derma Sciences (NASDAQ:DSCI) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $7.75 (96.70% upside)

Analysts' Ratings History for Derma Sciences (NASDAQ:DSCI)
Show:
DateFirmActionRatingPrice TargetActions
1/9/2016OppenheimerReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Canaccord GenuityDowngradeBuy -> Hold$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015Roth CapitalBoost Price TargetBuy$9.50 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/16/2015Piper JaffrayLower Price TargetNeutral$6.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Derma Sciences (NASDAQ:DSCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/11/2016Q116($0.13)($0.07)$20.60 million$20.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2016Q415($0.39)($0.38)$20.21 million$20.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315($0.43)($0.35)$22.31 million$22.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.43)($0.36)$21.66 million$22.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q115($0.46)($0.42)$19.89 million$19.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015Q414($0.45)($0.37)$22.90 million$22.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314($0.43)($0.45)$21.90 million$20.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q2($0.46)($0.34)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q1($0.32)($0.46)$19.79 million$19.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2014Q4($0.36)($0.31)$21.26 million$20.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2013Q3($0.44)($0.29)$21.96 million$22.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2013Q2 2013($0.45)($0.43)$19.95 million$18.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/16/2013Q1 2013($0.37)($0.38)$19.00 million$18.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2012Q312($0.37)($0.24)$19.00 million$19.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Derma Sciences (NASDAQ:DSCI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.13)($0.13)($0.13)
Q2 20161($0.08)($0.08)($0.08)
Q3 20161($0.03)($0.03)($0.03)
Q4 20161($0.02)($0.02)($0.02)
(Data provided by Zacks Investment Research)
Dividend History for Derma Sciences (NASDAQ:DSCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Derma Sciences (NASDAQ:DSCI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
8/18/2015Srini ConjeevaramDirectorBuy1,100$6.50$7,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2015Samuel E NavarroDirectorBuy10,000$6.51$65,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Bruce F WessonDirectorBuy10,000$6.58$65,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Edward J QuiltyCEOBuy15,000$6.65$99,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Robert C ColeInsiderBuy5,000$6.73$33,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Brett HewlettDirectorSell12,000$7.17$86,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Srini ConjeevaramDirectorSell12,500$8.49$106,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014C Richard StaffordDirectorSell6,075$8.59$52,184.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2014C Richard StaffordDirectorSell1,775$8.26$14,661.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2014C Richard StaffordDirectorSell3,250$8.59$27,917.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014C Richard StaffordDirectorSell1,800$8.50$15,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2014C Richard StaffordDirectorSell5,073$8.48$43,019.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2014Barry WolfensonInsiderBuy3,750$7.99$29,962.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Barry WolfensonInsiderBuy11,250$8.79$98,887.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2014Edward QuiltyCEOBuy10,000$8.70$87,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/10/2014Ra Capital Management, LlcInsiderSell300,000$11.83$3,549,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013C Richard StaffordDirectorSell15,000$14.06$210,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013John YetterCFOSell12,100$14.16$171,336.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/30/2013William C MartinMajor ShareholderSell95,568$13.68$1,307,370.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2013Ra Capital Management, LlcMajor ShareholderBuy3,945$11.40$44,973.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Derma Sciences (NASDAQ:DSCI)
DateHeadline
06/30/16 03:55 PMNew Study: Derma Sciences, Inc. (DSCI) - Financial and Strategic SWOT Analysis Review
06/30/16 08:17 AMDerma Sciences DE (NASDAQ:DSCI) Sellers Covered 8.8% of Their Shorts - Engelwood Daily
06/28/16 08:35 AMDerma Sciences DE (NASDAQ:DSCI) Shorted Shares Decreased By 8.8% - Press Telegraph
06/28/16 08:35 AMCovering the Bases on Derma Sciences, Inc. (NASDAQ:DSCI): Where is the Stock Going? - Press Telegraph
06/25/16 07:32 AMHow Many Derma Sciences Inc (NASDAQ:DSCI)'s Analysts Are Bearish? - Engelwood Daily
06/23/16 07:04 AMBrokers Issue Average Price Target Of 8.40 On Derma Sciences, Inc. (DSCI) - Fiscal Standard
06/21/16 08:21 AMThis Weeks Broker Views For Derma Sciences, Inc. (DSCI) - Fiscal Standard
06/18/16 03:23 PMDerma Sciences Inc. (DSCI) is Trading Lower on Unusual Volume for June 16
06/18/16 08:14 AMDerma Sciences, Inc. (DSCI) Current Analyst Ratings - Fiscal Standard
06/18/16 08:14 AMDerma Sciences Inc. (DSCI) is Trading Lower on Unusual Volume for June 16 - Equities.com
06/10/16 08:28 AMDerma Sciences Inc. (DSCI) is Trading Higher on Unusual Volume for June 08 - Equities.com
06/03/16 03:43 PMDERMA SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/01/16 03:52 PMBuy, Sell Or Hold Rating For Derma Sciences, Inc. (DSCI)? - Share Trading News - Buy, Sell Or Hold Rating For Derma Sciences, Inc. (DSCI)?Share Trading NewsDerma Sciences, Inc. has a 50 day moving average of 3.67 and a 200 day moving average of 3.69. The stock's market capitalization is 104.84M, it has a 52-week low of 2.85 and a 52-week high of 8.10. The share price of the company (DSCI) was up +0.00%, ...
05/24/16 07:35 AMWhy Derma Sciences (DSCI) Could Be Positioned for a Surge -
05/23/16 11:29 AMDerma Sciences, Inc. :DSCI-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 -
05/22/16 06:26 PMBuy Calls Count For Derma Sciences, Inc. (NASDAQ:DSCI) At 0 - Stocks Daily - Buy Calls Count For Derma Sciences, Inc. (NASDAQ:DSCI) At 0Stocks DailyZacks line of rating gives scores to firms on a basic 1-5 scale. As per this rating line, a score close to the lower band of 1-2 indicates a Buy, 3 rating calls for Hold while 4 or 5 rating denotes Sell. Most of the research firms have their self ...and more »
05/22/16 06:26 PMRevenue Update on Derma Sciences Inc(NASDAQ:DSCI) - Trade Calls - Trade CallsRevenue Update on Derma Sciences Inc(NASDAQ:DSCI)Trade CallsDerma Sciences Inc(NASDAQ:DSCI) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 11, 2016. Company reported revenue of $20.24M. Analysts estimated a revenue of $20.60M. Earnings per ...Are Analysts Bearish Derma Sciences Inc (NASDAQ:DSCI) After Last Week?Wall Street Hints and Newsall 2 news articles »
05/19/16 07:56 AMCan The Uptrend Continue for Derma Sciences (DSCI)? -
05/19/16 12:10 AMDerma Sciences Inc. (DSCI) is Trading Lower on Unusual Volume for May 17 - Equities.com - Derma Sciences Inc. (DSCI) is Trading Lower on Unusual Volume for May 17Equities.comDerma Sciences Inc. (DSCI) experienced unusually high volume on May. 17, as the stock lost 0.25% to a closing price of $3.98. The stock saw 86,252 shares trade hands over the course of the day on 490 trades. Given that the stock's average daily volume ...
05/17/16 11:52 PMDerma Sciences Inc. (DSCI) is Trading Higher on Unusual Volume for May 16 - Equities.com - Derma Sciences Inc. (DSCI) is Trading Higher on Unusual Volume for May 16Equities.comDerma Sciences Inc. (DSCI) experienced unusually high volume on May. 16, as the stock gained 4.72% to a closing price of $3.99. The stock saw 108,277 shares trade hands over the course of the day on 492 trades. Given that the stock's average daily ...
05/11/16 07:43 PMMoving Stocks: Pfizer Inc. (NYSE:PFE), Derma Sciences Inc. (NASDAQ:DSCI), PharmAthene, Inc. (NYSEMKT:PIP ... - KC Register - Moving Stocks: Pfizer Inc. (NYSE:PFE), Derma Sciences Inc. (NASDAQ:DSCI), PharmAthene, Inc. (NYSEMKT:PIP ...KC RegisterDerma Sciences Inc. (NASDAQ:DSCI) announced that it will hold a conference call on May 11, 2016 to discuss the financial results for the first quarter of 2016. In addition, management will provide a business update and a discussion on recent and ...
05/11/16 06:52 AMDerma Sciences Reports 2016 First Quarter Financial Results - [at noodls] - Net sales up 3.8% with Advanced Wound Care sales up 8.5% Affirms 2016 financial guidance Conference call begins at 11:00 a.m. Eastern Time today PRINCETON, N.J.--(BUSINESS WIRE)--May 11, 2016-- Derma Sciences, ...
05/11/16 06:37 AMDerma Sciences reports 1Q loss -
05/10/16 07:27 PMConsensus Rating Review for Derma Sciences, Inc. (NASDAQ:DSCI) - B.O.D.Y Confidential - Consensus Rating Review for Derma Sciences, Inc. (NASDAQ:DSCI)B.O.D.Y ConfidentialEquity research analysts currently have a consensus rating of 2 on shares of Derma Sciences, Inc. (NASDAQ:DSCI). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy, Sell, or ...and more »
05/10/16 07:27 PMDerma Sciences Inc. (DSCI) Jumps 6.38% on May 10 - Equities.com - Derma Sciences Inc. (DSCI) Jumps 6.38% on May 10Equities.comDerma Sciences Inc. (DSCI) was among the biggest gainers on the Russell 2000 for Tuesday May 10 as the stock popped 6.38% to $3.50, representing a gain of $0.21 per share. Some 17,425 shares traded hands on 130 trades, compared with an average ...and more »
05/10/16 04:21 PMDERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report -
05/09/16 02:07 AMNext Weeks Broker Price Targets For Derma Sciences, Inc. (DSCI) - Share Trading News - Next Weeks Broker Price Targets For Derma Sciences, Inc. (DSCI)Share Trading NewsDerma Sciences, Inc. has a 50 day moving average of 3.39 and a 200 day moving average of 3.86. The stock's market capitalization is 82.58M, it has a 52-week low of 2.85 and a 52-week high of 8.10. The share price of the company (DSCI) was up +0.00%, ...Are Analysts Bullish Derma Sciences Inc (NASDAQ:DSCI) After Last Week?Franklin Independentall 3 news articles »
05/06/16 07:28 PMDerma Sciences Inc.: Derma Sciences to Hold First Quarter Financial Results Conference Call on May 11th - PRINCETON, N.J.--(BUSINESS WIRE)--May 6, 2016-- Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announced today that it will hold a conference call on May 11, 2016 to discuss the financial results ...
05/06/16 01:44 PMDerma Sciences to Hold First Quarter Financial Results Conference Call on May 11th - [at noodls] - PRINCETON, N.J.--(BUSINESS WIRE)--May 6, 2016-- Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announced today that it will hold a conference ...
05/05/16 08:18 PMEarnings Outlook on Derma Sciences, Inc. (NASDAQ:DSCI) - B.O.D.Y Confidential - Earnings Outlook on Derma Sciences, Inc. (NASDAQ:DSCI)B.O.D.Y ConfidentialAnalysts and investors will be anticipating Derma Sciences, Inc. (NASDAQ:DSCI)'s next earnings release which is expected to be posted on or around 2016-05-09. Sell-side research firms on Wall Street are expecting that the company will post EPS of $-0 ...and more »
05/03/16 07:15 PMAverage Analyst Rating for Derma Sciences, Inc. (NASDAQ:DSCI) - B.O.D.Y Confidential - Average Analyst Rating for Derma Sciences, Inc. (NASDAQ:DSCI)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 2 on Derma Sciences, Inc. (NASDAQ:DSCI) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
04/27/16 07:11 AMDerma Sciences Announces AMNIOEXCEL® Is Now Eligible for Reimbursement by Medicare Administrative Contractor CGS - [at noodls] - Cost-effective AMNIOEXCEL allograft now covered and reimbursed under six of eight MAC regions PRINCETON, N.J.--(BUSINESS WIRE)--Apr. 27, 2016-- Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration ...
04/27/16 06:32 AM7:32 am Derma Sciences announces that CGS Administrators has updated its local coverage determination for cellular or tissue-based products of the lower extremity -
04/26/16 07:19 PMDerma Sciences, Inc. (NASDAQ:DSCI) Share Rating Recap - B.O.D.Y Confidential - Derma Sciences, Inc. (NASDAQ:DSCI) Share Rating RecapB.O.D.Y ConfidentialShares of Derma Sciences, Inc. (NASDAQ:DSCI) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from ...
04/26/16 07:19 PMDerma Sciences, Inc. (DSCI) - Broker Update - Risers & Fallers - Derma Sciences, Inc. (DSCI) - Broker UpdateRisers & FallersDerma Sciences, Inc. (Derma Sciences) is a tissue regeneration company, which is engaged in the research and management of acute and chronic wounds, and burns. The Company operates through three segments: pharmaceutical wound care, advanced ...
04/24/16 09:42 PMDerma Sciences, Inc. (DSCI) Broker Price Targets For The Coming Week - Share Trading News - Derma Sciences, Inc. (DSCI) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Derma Sciences, Inc. (DSCI). The latest reports which are currently in issue on Sunday 24th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
04/22/16 09:02 PMHow Analysts Feel About Derma Sciences Inc (NASDAQ:DSCI)? - The Post - How Analysts Feel About Derma Sciences Inc (NASDAQ:DSCI)?The PostOut of 1 analysts covering Derma Sciences (NASDAQ:DSCI), 1 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Derma Sciences has been the topic of 6 analyst reports since August 11, 2015 according to StockzIntelligence Inc. Below ...
04/22/16 09:02 PMLatest Analyst Reports On Derma Sciences, Inc. - Risers & Fallers - Latest Analyst Reports On Derma Sciences, Inc.Risers & FallersDerma Sciences, Inc. has a 50 day moving average of 3.28 and a 200 day moving average of 3.99. The stock's market capitalization is 91.61M, it has a 52-week low of 2.85 and a 52-week high of 8.56. The share price of the company (DSCI) was down -3.01%, ...
04/20/16 08:29 PMBroker Roundup For Derma Sciences, Inc. (DSCI) - Share Trading News - Broker Roundup For Derma Sciences, Inc. (DSCI)Share Trading News12/13/2013 – Derma Sciences, Inc. was downgraded to “sell” by analysts at TheStreet. The share price of Derma Sciences, Inc. (DSCI) was up +0.56% during the last trading session, with a day high of 3.61. 18837 shares were traded on Derma Sciences, ...
04/18/16 09:11 PMDerma Sciences, Inc. (NASDAQ:DSCI) Analyst Rating Review - Clinton Financial - Derma Sciences, Inc. (NASDAQ:DSCI) Analyst Rating ReviewClinton FinancialCovering analysts typically give Buy, Sell and Hold recommendations along with guidance and company earnings projections. Currently, there are 2 analysts that have provided ratings for Derma Sciences, Inc. (NASDAQ:DSCI). 1 have rated the stock a ...and more »
04/15/16 08:45 PMLatest Analyst Ratings For Derma Sciences, Inc. (DSCI) - Share Trading News - Latest Analyst Ratings For Derma Sciences, Inc. (DSCI)Share Trading NewsDerma Sciences, Inc. has a 50 day moving average of 3.24 and a 200 day moving average of 4.03. The stock's market capitalization is 90.06M, it has a 52-week low of 2.85 and a 52-week high of 8.72. The share price of the company (DSCI) was down -0.57%, ...
04/04/16 12:59 PMEdited Transcript of DSCI earnings conference call or presentation 16-Mar-16 3:00pm GMT -
03/19/16 12:04 PMDERMA SCIENCES, INC. Financials -
03/16/16 10:00 AMDerma Sciences Inc Earnings Call scheduled for 11:00 am ET today -
03/16/16 07:30 AMMedical Products Companies Tap Into $50 Billion U.S. Government GSA Supply Program - [Accesswire] - REDONDO BEACH, CA / ACCESSWIRE / March 16, 2016 / Last week, BioLargo, Inc. (OTC: BLGO), best known for the AOS Filter that has demonstrated the highest impact and lowest cost of any known water treatment ...
03/16/16 06:49 AMDerma Sciences reports 4Q loss -
03/16/16 06:30 AMDerma Sciences Reports 2015 Fourth Quarter and Full Year Financial Results - [Business Wire] - Derma Sciences, Inc. , a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three and 12 months ended December 31, 2015.
03/16/16 06:07 AMQ4 2015 Derma Sciences Inc Earnings Release - Before Market Open -
03/15/16 04:18 PMDERMA SCIENCES, INC. Files SEC form 10-K, Annual Report -
01/20/16 07:00 AMBioLargo Closes Financing To Advance Its Novel Wound Care Products - [Accesswire] - REDONDO BEACH, CA / ACCESSWIRE / January 20, 2016 / BioLargo, Inc. (OTC: BLGO) recently announced that its subsidiary, Clyra Medical Technologies, secured a $5.75 million financing package for Its Advanced ...
About Derma Sciences

Derma Sciences logoDerma Sciences, Inc. (Derma Sciences) is a tissue regeneration company, which is engaged in the research and management of acute and chronic wounds, and burns. The Company operates through three segments: pharmaceutical wound care, advanced wound care and traditional wound care products. Pharmaceutical wound care products consist of DSC127, a product for the treatment of a variety of dermal applications, including diabetic foot ulcers and scar prevention. DSC127 for diabetic foot ulcers is in Phase III of clinical development and in pre-clinical stage of scar prevention. Advanced wound care products consist of differentiated dressings, bandages and ointments for wound healing and/or prevent infection, including MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closer strips, catheter fasteners and skin care products.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: DSCI
  • CUSIP: 24982750
Key Metrics:
  • Previous Close: $3.94
  • 50 Day Moving Average: $3.96
  • 200 Day Moving Average: $3.64
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $101.99M
  • Current Quarter EPS Consensus Estimate: $-0.20 EPS
Additional Links:
Derma Sciences (NASDAQ:DSCI) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha